Abstract submission is now closed.
Thank you to everyone who submitted abstracts, the review process will now begin. If you submitted an abstract you will receive an email informing you of whether you have been successful or not. These emails will be issued in March 2018 alongside further details of the next steps.
In the meantime, if you have any questions please contact Katie Bingham at [email protected]
- Awareness and stigma
- Carer support and training
- Dementia friendly communities
- Dementia policies and public policy initiatives
- Diagnosis and imaging
- Diverse populations – inclusion and equality
- Education and training of the workforce
- End of life care
- Engaging people living with dementia and care partners
- Environment and technology
- Mild cognitive impairment (MCI)
- Models of care
- Prevention (risk reduction and risk factors)
- Psychosocial interventions
- Rights of people with dementia
- Technology, innovation and entrepreneurship
- Treatments and clinical trials
- Well-being and quality of life
- Younger onset dementia
Abstracts received after the deadline will not be accepted.
- Presenting author: person who will physically present the abstract at the conference and who is marked as the presenter in the program
- Author(s): person or persons who wrote the abstract
It is important to ADI that presenters use appropriate language and we would encourage all those submitting an abstract to look at the language guidelines created by Dementia Australia in collaboration with people living with dementia. They are to be used when writing your abstract and presenting at ADI conferences, as well as other conferences. It is important that you as presenters follow these guidelines in your abstract submissions, and if successful, in your oral or poster presentations.
The following points highlight preferred terms next to the terms we advise submitters not to use:
- Dementia/a form or type of dementia/symptoms of dementia – not Dementing illness, Senile dementia
- Person living with dementia, diagnosed with dementia – not Sufferer, Victim, Demented person, Patient (unless in a specific medical context)
- Younger onset dementia – not Early onset dementia
All abstracts must be written in English using the Roman alphabet.
Failure to observe these guidelines may result in disqualification.
- Click on the “ABSTRACTS” section of this website and follow instructions as given.
- An email from [email protected] will be sent to the submitter at step 1, this will include you abstract ID, password and direct link
- The correct topic must be selected to ensure correct scoring. The content of the abstract must be topic related.
- Abstracts must contain data and meet international ethical standards.
- Abbreviations should be defined.
- Trade names cannot be mentioned in the title. However, trade names in brackets will be accepted in the body of the text.
- You must disclose if the presenter has a conflict of interest.
- The abstract title cannot contain more than 255 characters (excluding blank spaces).
- The title must be written in sentence case, with only the first word and proper nouns starting with a capital letter.
- The abstract cannot contain more than 3000 characters (excluding blank spaces).
- The abstract can be structured in two ways:
Scientific abstracts must be structured into the following sections:
You will find these already in the text box for you. Each section heading must be followed by a colon.
For Non scientific abstracts it is not necessary to provide Objectives, Methods, Results and Conclusions – please submit the entire abstract in the text box.
- Tables can be included, either by creating the table using the abstract system or copying and pasting them in. Please note that tables may significantly reduce the number of available characters.
- You may upload an image in addition to the text of the abstract. Only .jpg, .png, and .gif image files smaller than 5 MB are allowed.
- If you have successfully submitted your abstract, you will receive a confirmation number. If no confirmation number is received, the abstract cannot be considered as successfully submitted and accepted.
- Submitted abstracts can be re-edited and modified until the submission deadline. Once you have commenced writing your abstract you will be asked to enter a submitters email address. You will be sent a confirmation email, reminding you that you started an abstract submission and explaining how you can access that submission again to enable you to subsequently modify / submit any new abstracts. To save the abstract, all required fields (marked with an *) must be filled in. The submitted abstracts cannot be edited after the submission deadline.
- Please ensure that your abstract does not contain spelling, grammatical or scientific errors. No corrections are possible after the submission deadline. The abstract will be reproduced exactly as submitted in the abstract book. No proofreading will be done.
- If you need to withdraw your abstract, you can do this via the abstract submission website. Please provide a reason for your withdrawal so that we can be sure this wasn’t done accidentally.
- There is no limit to the number of abstracts that can be submitted by one person.
- The reviewers will judge the abstracts according to the relevance to the ADI 2018 conference, standard of English, objectivity of statements, description of what was done, suitability of methods to aims, conclusions confirmed by objective results, ethics, scientific value, potential clinical value, originality of work and overall impression.
- The submitting authors will be notified in April 2018, at the email address provided during submission, whether their abstract has been accepted. It is the author’s responsibility to ensure that emails from ADI can reach them. They will be informed at the same time about the date, time and form of their presentation.
All abstracts accepted for presentation (oral or poster) will be published in the official abstract book of the conference.
Presentation of abstracts
- Abstracts can be accepted either as a poster, or oral presentation.
- If your abstract is accepted as a poster, you will be requested to be available for discussion during the corresponding moderated poster viewing session. Please use letters large enough to be read from a distance of 1.5 meters (4.9 feet).
- Oral presentations will be advised of presentation date and length of presentation once abstract has been accepted.
- Full presentation guidelines will be included in the acceptance letter and posted on the conference website.